Five nations have come out in support of livestock cloning as one of many agricultural technologies that can help meet our growing demand for sustainable food production.
Industry analysts are projecting double digit growth in the biobased product sector, and an overwhelming majority of company executives are optimistic about company and industry growth potential, according to recent research.
NIH Director Francis Collins, MD, PhD will share his insights on how ground-breaking biotech innovations can serve the health needs of the world’s poorest.
The Award will be given to an individual who, through their work in or support of biotechnology, is harnessing its potential to heal, fuel or feed the planet.
The Virginia Refundable Research and Development Tax Credit, recently passed by the Virginia House and Senate, is a successfully proven incentive to create new jobs and enable small and large companies to advance new products and technologies.
The 2011 BIO International Convention will feature six high-level super sessions focused on the state of the industry, global biotech advancements and the outlook on the future of the industry.
The fourth annual George Washington Carver Award will recognize an individual who has demonstrated significant and innovative accomplishments that have employed industrial biotechnology to facilitate the advancement of a biobased economy and industrial sustainability.
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2010, says a record 15.4 million farmers in 29 countries are growing biotech crops on 366 million acres.
The Biotechnology Industry Organization (BIO) stresses the critical importance of protecting intellectual property abroad in comments recently filed with the U.S. Trade Representative (USTR) on the 2011 Special 301 Review.
Brent Erickson, executive vice president of the Biotechnology Industry Organization’s (BIO) Industrial & Environmental Section, has been named to the Scientific Advisory Board of the Synthetic Biology Engineering Research Center (SynBERC).
Biotechnology Industry Organization (BIO) Industry Analysis and BioMedTracker (BMT) announced results of a study today that shows the overall success rate for drugs moving through clinical trials to FDA approval from late 2003 to the end of 2010 is near one in 10.
According to a new survey of CEOs of small biotech firms that received Therapeutic Discovery Project awards last fall, the TDP is important to the viability of the companies receiving the award and allowed these small businesses to create or sustain jobs.
BIO announces that former Senator John B. Breaux (D-LA), former Member, Senate Finance Committee, along with former Congressman Jim McCrery III (R-LA), former Ranking Member, House Ways & Means Committee, will be panelists at the 13th Annual BIO CEO & Investor Conference.
BIO and several of its member companies will offer input on progress and potential adjustments to the LCFS as a member of the California Air Resources Board Low Carbon Fuel Standard Advisory Panel.
Since 1995, Pellerito has served as an industry member representative of BIO’s Federal Government Relations and State Government Relations Committees, as well as an economic development and university outreach consultant.
The USDA announces that it will issue a “partial deregulation” for the most popular variety of sugar beets, Roundup Ready (RR) sugar beets, which are genetically engineered to tolerate the herbicide glyphosate.
